Baxter International

Baxter International

Every day, Baxter touches the lives of millions of patients and providers worldwide who rely on our essential hospital and renal products and services.

Launch date
Employees
Market cap
AUD31.0b
Enterprise valuation
AUD48.4b (Public information from Sep 2024)
Deerfield Illinois (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD2020202120222023202420252026
Revenues11.7b12.8b15.1b14.8b15.2b15.7b16.3b
% growth3 %10 %18 %(2 %)3 %3 %4 %
EBITDA1.4b1.7b854m1.8b2.9b3.1b3.3b
% EBITDA margin12 %13 %6 %12 %19 %20 %20 %
Profit1.1b1.3b(2.4b)2.7b369m878m1.1b
% profit margin9 %10 %(16 %)18 %2 %6 %7 %
EV / revenue3.7x4.5x2.7x2.0x1.9x1.9x1.8x
EV / EBITDA30.5x34.6x47.6x17.3x10.1x9.3x8.8x
R&D budget521m534m605m667m---
R&D % of revenue4 %4 %4 %5 %---

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
-

N/A

-

$635m

Acquisition
Total Funding-

Recent News about Baxter International

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
  • Edit
Cheetah Medical
ACQUISITION by Baxter International Sep 2019
FLOWSENSE
ACQUISITION by Baxter International Sep 2013
Prism Pharmaceuticals
ACQUISITION by Baxter International Apr 2011
Naurex
ACQUISITION by Allergan Jul 2015
AesRx
ACQUISITION by Baxter International Jul 2014
Gambro
ACQUISITION by Baxter International Sep 2013
View 11 more